Card
Series GSE275043 Query DataSets for GSE275043
Status Public on Mar 19, 2025
Title Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia [CRISPR]
Organism Homo sapiens
Experiment type Other
Summary Galectin-9 is overexpressed in a variety of cancers and associated with worse clinical outcome in some cancers. However, the regulators driving Galectin-9 expression are unknown. Here, we defined the transcriptional regulators and epigenetic circuitry of Galectin-9 in pediatric T cell acute lymphoblastic leukemia (T-ALL), as an example of a disease with strong Galectin-9 expression, in which higher expression was associated with lower overall survival. By performing a genome-wide CRISPR screen, we identified the transcription factors IRF1 and TFAP4 as key regulators for Galectin-9 expression by binding its regulatory elements. While IRF1 was observed exclusively on the promoter, TFAP4 binding was detected at an enhancer solely in T-ALL cells associated with higher Galectin-9 levels. Together, our results show that IRF1 is responsible and indispensable for Galectin-9 expression and TFAP4 further fine-tunes its expression. Our approach, a flow-based genome-wide CRISPR screen complemented by transcription factor binding and enhancer mapping, creates innovative opportunities for understanding and manipulating epigenetic transcriptional regulation in cancer.
 
Overall design Genome-wide CRISPR screen (Brunello library) of Galectin-9 in T-ALL cell line Jurkat
 
Contributor(s) Wiggers CR, Yüzügüldü B, Lohr JG, Knoechel B
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Aug 16, 2024
Last update date Mar 20, 2025
Contact name Birgit Knoechel
E-mail(s) birgit.knoechel@hci.utah.edu
Organization name HCI
Street address 2000 Circle of Hope
City Salt Lake City
ZIP/Postal code 84112
Country USA
 
Platforms (1)
GPL18573 Illumina NextSeq 500 (Homo sapiens)